Sessioni Poster


Ion channels and transport mechanisms

Thursday, October 26th / 19.00-21.00
117SEARCHING FOR NOVEL DRUGS IN MYOTONIA CONGENITA: EVALUATION OF ANTHRACENE-9-CARBOXYLIC ACID AND NIFLUMIC ACID BINDING SITES AND CHAPERONE ACTIVITY ON CLC-1 CHLORIDE CHANNEL MUTANTS.
Altamura C., Imbrici P., Sahbani D., Toscano A., Mantegazza R., Lo Monaco M., Mangiatordi G.F., Nicolotti O., Carratù M.R., Desaphy J.F., Conte Camerino D.
202SKELETAL MUSCLE CLC-1 CHANNEL: FROM GENE TO PROTEIN, FROM BIRTH TO AGING TOWARD A PERSONALIZED MEDICINE
Conte E., Fonzino A., Cibelli A., De luca A., Pierno S., Nicchia GP., Camerino GM.
249DEVELOPMENT OF NEW BENZOTHIAZOLAMINES TO ENHANCE USE-DEPENDENT INHIBITION OF VOLTAGE-GATED SODIUM CHANNELS.
Farinato A., Altamura C., Cavaluzzi MM., Lentini G., Carratù MR., Conte camerino D., Desaphy JF.
302BARTTER'S SYNDROME AND KIDNEY CLC-K CHANNELS: A PHARMACOVIGILANCE-BASED DRUG DISCOVERY STRATEGY TO REPROFILE SARTANS AS NOVEL LIGANDS
Imbrici P., Tricarico D., Mangiatordi GF., Nicolotti O., Conte D., Liantonio A.
309FUNCTIONAL COMPARISON AMONG THREE VARIANTS AFFECTING THE SAME CRITICAL RESIDUE IN THE Kv7.2 POTASSIUM CHANNEL GENE IDENTIFIED IN PATIENTS WITH EPILEPSY AND/OR SEVERE DEVELOPMENTAL IMPAIRMENT
Lauritano A., Miceli F., Cimino M., Onore ME., Nappi P., Weckhuysen S., Cooper EC., Taglialatela M.
327STARGAZIN REGULATES THE BIOCHEMICAL AND FUNCTIONAL PROPERTIES OF Kv7.2 VOLTAGE-GATED POTASSIUM CHANNELS
Manocchio L., Soldovieri MV., Ambrosino P., Mosca I., Caldeira G., Rodrigues M., Carvalho AL., Taglialatela M.
352Compound heterozygosis in the kcnq3 gene in a patient with early-onset Epileptic Encephalopathy (EOEE)
Mosca I.., Soldovieri MV., Ambrosino P.., Freri E.., Castellotti B.., Gellera C.., Difrancesco JC., Taglialatela M..
400Understanding the pathogenesis of oxaliplatin-induced peripheral neurotoxicity
Riva B., Potenzieri A., Lim D., Dionisi M., Carozzi V., Cavaletti G., Distasi C., Genazzani A.A.